Please enable JavaScript to continue using this application.

Compare $BDTX vs $IMUX | Chartloom

Compare

$BDTX vs $IMUX

Black Diamond Therapeutics Inc · Immunic Inc

BDTX

Black Diamond Therapeutics Inc

IMUX

Immunic Inc

Compare $BDTX vs $IMUX

Comparing Black Diamond Therapeutics Inc and Immunic Inc

BDTXBlack Diamond Therapeutics Inc

IMUXImmunic Inc

BDTXBlack Diamond Therapeutics Inc

Market cap

$105M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-26.5%

52W performance

-54.1%

FCF yield

-31.3%

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDTX

IMUX

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

IMUX

Immunic Inc

Market Cap

BDTX$105M

IMUX$112M

Enterprise Value

BDTX$86M

IMUX$-44M

Price

BDTX$1.83

IMUX$8.19

P/E Ratio

BDTXN/A

IMUXN/A

P/S Ratio

BDTX0.00x

IMUX0.00x

EV/Sales

BDTX0.00x

IMUX0.00x

EV/EBITDA

BDTX6.96x

IMUX0.00x

P/B Ratio

BDTX1.13x

IMUX0.85x

P/FCF Ratio

BDTXN/A

IMUXN/A

EV/FCF

BDTX-2.61x

IMUX0.49x

PEG Ratio

BDTXN/A

IMUXN/A

Forward P/E (NTM)

BDTXN/A

IMUXN/A

Forward P/S (NTM)

BDTXN/A

IMUXN/A

Revenue (TTM)

BDTX$0

IMUX$0

Revenue Growth (YoY)

BDTX-100.0%

IMUXN/A

Forward Rev Growth

BDTX533.3%

IMUX650.4%

Gross Margin (TTM)

BDTX0.0%

IMUX0.0%

Operating Margin (TTM)

BDTX0.0%

IMUX0.0%

EBITDA Margin (TTM)

BDTX0.0%

IMUX0.0%

Net Margin (TTM)

BDTX0.0%

IMUX0.0%

FCF Margin (TTM)

BDTXN/A

IMUXN/A

Net Income (TTM)

BDTX$-43M

IMUX$-112M

FCF (TTM)

BDTX$-33M

IMUX$-88M

EPS (TTM)

BDTX-$0.74

IMUX-$2.62

ROE (TTM)

BDTX-3880.0%

IMUX-9567.0%

ROA (TTM)

BDTX-3047.0%

IMUX-10788.0%

ROIC (TTM)

BDTX-3880.0%

IMUX-9567.0%

Cash

BDTX$19M

IMUX$155M

Debt

BDTX$0

IMUX$0

Net Cash/Debt

BDTX$19M

IMUX$155M

Current Ratio (TTM)

BDTX7.28x

IMUX5.05x

Quick Ratio (TTM)

BDTX6.98x

IMUX5.00x

Debt/Equity (TTM)

BDTX0.00x

IMUX0.00x

Debt/Assets (TTM)

BDTX0.0%

IMUX0.0%

Interest Coverage (TTM)

BDTXN/A

IMUXN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

IMUX0.00x

Beta

BDTX3.41

IMUX1.47

52W Performance

BDTX-54.1%

IMUX-8.8%

YTD Performance

BDTX-26.5%

IMUX40.5%

% from 52W High

BDTX-63.0%

IMUX-53.0%

% from 52W Low

BDTX14.4%

IMUX61.9%

Asset Turnover (TTM)

BDTX0.00x

IMUX0.00x

FCF Yield (TTM)

BDTX-31.3%

IMUX-78.9%

Earnings Yield (TTM)

BDTX-40.6%

IMUX-100.0%

Dividend Yield (TTM)

BDTXN/A

IMUXN/A

Rule of 40

BDTX-100.0

IMUX0.0

EV/GP/RG

BDTXN/A

IMUXN/A

Ticker research

View BDTX research View IMUX research

Metric	BDTX Black Diamond Therapeutics Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$105M	$112M
Enterprise Value	$86M	$-44M
Price	$1.83	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	533.3%	650.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-112M
FCF (TTM)	$-33M	$-88M
EPS (TTM)	-$0.74	-$2.62
ROE (TTM)	-3880.0%	-9567.0%
ROA (TTM)	-3047.0%	-10788.0%
ROIC (TTM)	-3880.0%	-9567.0%
Financial Health
Cash	$19M	$155M
Debt	$0	$0
Net Cash/Debt	$19M	$155M
Current Ratio (TTM)	7.28x	5.05x
Quick Ratio (TTM)	6.98x	5.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	1.47
52W Performance	-54.1%	-8.8%
YTD Performance	-26.5%	40.5%
% from 52W High	-63.0%	-53.0%
% from 52W Low	14.4%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.3%	-78.9%
Earnings Yield (TTM)	-40.6%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View IMUX research

Valuation

P/S Ratio

BDTX

0.00x

IMUX

0.00x

EV/FCF

BDTX

-2.61x

IMUX

0.49x

Growth & revenue

Revenue Growth TTM

BDTX

-100.0%

Forward Revenue Growth

IMUX

650.4%

BDTX

533.3%

Profitability & performance

Gross Margin

BDTX

0.0%

IMUX

0.0%

ROE

BDTX

-3880.0%

IMUX

-9567.0%

FCF Yield %

BDTX

-31.3%

IMUX

-78.9%

52-Week Performance

IMUX

-8.8%

BDTX

-54.1%

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

IMUX

Immunic Inc

Market Cap

BDTX$105M

IMUX$112M

Enterprise Value

BDTX$86M

IMUX$-44M

Price

BDTX$1.83

IMUX$8.19

P/E Ratio

BDTXN/A

IMUXN/A

P/S Ratio

BDTX0.00x

IMUX0.00x

EV/Sales

BDTX0.00x

IMUX0.00x

EV/EBITDA

BDTX6.96x

IMUX0.00x

P/B Ratio

BDTX1.13x

IMUX0.85x

P/FCF Ratio

BDTXN/A

IMUXN/A

EV/FCF

BDTX-2.61x

IMUX0.49x

PEG Ratio

BDTXN/A

IMUXN/A

Forward P/E (NTM)

BDTXN/A

IMUXN/A

Forward P/S (NTM)

BDTXN/A

IMUXN/A

Revenue (TTM)

BDTX$0

IMUX$0

Revenue Growth (YoY)

BDTX-100.0%

IMUXN/A

Forward Rev Growth

BDTX533.3%

IMUX650.4%

Gross Margin (TTM)

BDTX0.0%

IMUX0.0%

Operating Margin (TTM)

BDTX0.0%

IMUX0.0%

EBITDA Margin (TTM)

BDTX0.0%

IMUX0.0%

Net Margin (TTM)

BDTX0.0%

IMUX0.0%

FCF Margin (TTM)

BDTXN/A

IMUXN/A

Net Income (TTM)

BDTX$-43M

IMUX$-112M

FCF (TTM)

BDTX$-33M

IMUX$-88M

EPS (TTM)

BDTX-$0.74

IMUX-$2.62

ROE (TTM)

BDTX-3880.0%

IMUX-9567.0%

ROA (TTM)

BDTX-3047.0%

IMUX-10788.0%

ROIC (TTM)

BDTX-3880.0%

IMUX-9567.0%

Cash

BDTX$19M

IMUX$155M

Debt

BDTX$0

IMUX$0

Net Cash/Debt

BDTX$19M

IMUX$155M

Current Ratio (TTM)

BDTX7.28x

IMUX5.05x

Quick Ratio (TTM)

BDTX6.98x

IMUX5.00x

Debt/Equity (TTM)

BDTX0.00x

IMUX0.00x

Debt/Assets (TTM)

BDTX0.0%

IMUX0.0%

Interest Coverage (TTM)

BDTXN/A

IMUXN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

IMUX0.00x

Beta

BDTX3.41

IMUX1.47

52W Performance

BDTX-54.1%

IMUX-8.8%

YTD Performance

BDTX-26.5%

IMUX40.5%

% from 52W High

BDTX-63.0%

IMUX-53.0%

% from 52W Low

BDTX14.4%

IMUX61.9%

Asset Turnover (TTM)

BDTX0.00x

IMUX0.00x

FCF Yield (TTM)

BDTX-31.3%

IMUX-78.9%

Earnings Yield (TTM)

BDTX-40.6%

IMUX-100.0%

Dividend Yield (TTM)

BDTXN/A

IMUXN/A

Rule of 40

BDTX-100.0

IMUX0.0

EV/GP/RG

BDTXN/A

IMUXN/A

Ticker research

View BDTX research View IMUX research

Metric	BDTX Black Diamond Therapeutics Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$105M	$112M
Enterprise Value	$86M	$-44M
Price	$1.83	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	533.3%	650.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-112M
FCF (TTM)	$-33M	$-88M
EPS (TTM)	-$0.74	-$2.62
ROE (TTM)	-3880.0%	-9567.0%
ROA (TTM)	-3047.0%	-10788.0%
ROIC (TTM)	-3880.0%	-9567.0%
Financial Health
Cash	$19M	$155M
Debt	$0	$0
Net Cash/Debt	$19M	$155M
Current Ratio (TTM)	7.28x	5.05x
Quick Ratio (TTM)	6.98x	5.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	1.47
52W Performance	-54.1%	-8.8%
YTD Performance	-26.5%	40.5%
% from 52W High	-63.0%	-53.0%
% from 52W Low	14.4%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.3%	-78.9%
Earnings Yield (TTM)	-40.6%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View IMUX research